New blood test safety check for rare disease drug monitoring
NCT ID NCT07573059
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the safety of a special blood test system used to measure arginine levels in people with ARG1 deficiency who are taking the drug Loargys. The test system includes special blood collection tubes that stop the drug from breaking down arginine after the sample is taken. About 100 participants will be enrolled to see if any side effects occur from using this test system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Loargys Arginine Test System (special blood collection tubes and lab test)
- What this could lead to
- If successful, this study could confirm that the test system is safe for monitoring arginine levels in patients on Loargys, supporting its routine use.
- What could go wrong
- This is a small, early safety study with no control group, so it cannot prove effectiveness. The test system may still have rare or unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARG1 DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Rare Disease Research
RECRUITINGAtlanta, Georgia, 303029, United States